Lixte Biotechnology Holdings
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$5,087,029 over the previous period. Total operating expenses were $5,090,236.

Profit Margin

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW): Profit margin
2014 0 -2.76M
2015 200K -2.85M -1426.05%
2016 0 -2.13M
2017 0 -1.80M
2018 0 -2.13M
2019 0 -2.39M
2020 0 -3.26M
2021 0 -6.73M
2022 0 -6.30M
2023 0 -5.08M

LIXTW Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
00000000200K0
Cost of revenue
0000000000
Gross profit
00000000200K0
Operating exp.
Research and development
898.1K1.34M1.73M1.22M820.90K40.70K467.25K1.30M2.09M1.11M
Selling and marketing
0000000000
Total operating expenses
5.09M6.31M6.72M3.26M2.49M2.13M1.80M2.13M2.84M2.40M
Operating income
-5.09M-6.31M-6.72M-3.26M-2.49M-2.13M-1.80M-2.13M-2.64M-2.40M
Other income (expenses), net
3.20K-1.05K-7.95K1.55K49.72K4.92K1.37K183-205.69K-363.04K
Income before tax
-5.08M-6.31M-6.72M-3.26M-2.44M-2.13M-1.80M-2.13M-2.85M-2.76M
Income tax expense
0-7.82K6.78K-1.55K-49.72K-9.84K-1.80K-2.13K-78-66
Net income
-5.08M-6.30M-6.73M-3.26M-2.39M-2.13M-1.80M-2.13M-2.85M-2.76M
Earnings per share
Basic EPS
-2.66-39.85-5-2.89-2.14-2.18-1.94-2.68-3.66-3.74
Diluted EPS
-2.66-39.85-5-2.89-2.14-2.18-1.94-2.68-3.66-3.74
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source